USR Unitat Transversal de Recerca

avatar_grups_recerca.png

Publications

Multimorbidity patterns in COVID-19 patients and their relationship with infection severity: MRisk-COVID study

M. LLEAL, C. CORRAL-VAZQUEZ, M. BARÉ, R. COMET, S. HERRANZ, F. BAIGORRI, A. GIMENO-MIGUEL, M. RAURICH, C. FORTIÀ, M. NAVARRO, B. POBLADOR-PLOU and M. BARÉ
PLoS One. 2023 Aug 31; . doi:10.1371/journal.pone.0290969; PMID:37651465

Association of depression phenotypes and antidepressant treatment with mortality due to cancer and other causes: a community-based cohort study

A. VILALTA-LACARRA, J. VILALTA-FRANCH, D. SERRANO-SARBOSA, R. MARTÍ-LLUCH, J. MARRUGAT and J. GARRE-OLMO
Frontiers in Psychology. 2023 Aug 24; . doi:10.3389/fpsyg.2023.1192462; PMID:37711322

Epidemiology of the first-ever cardiovascular event in people with type 1 diabetes: a retrospective cohort population-based study in Catalonia

G. GIMENEZ-PEREZ, C. VINALS, M. MATA-CASES, B. VLACHO, J. REAL, J. FRANCH-NADAL, E. ORTEGA and D. MAURICIO
Cardiovascular Diabetology. 2023 Jul 14; . doi:10.1186/s12933-023-01917-1; PMID:37452416

Blue prescription: A pilot study of health benefits for oncological patients of a short program of activities involving the sea

A. CARREÑO, E. FONTDECABA, A. IZQUIERDO, O. ENCISO, P. DAUNIS-I-ESTADELLA, G. MATEU-FIGUERAS, J. PALAREA-ALBALADEJO, M. GASCON, C. VENDRELL, M. LLOVERAS, J. SAN, S. GÓMEZ, S. MINUTO and J. LLORET
Heliyon. 2023 Jul 1; . doi:10.1016/j.heliyon.2023.e17713; PMID:37483694

SMA-TB: study protocol for the phase 2b randomized double-blind, placebo-controlled trial to estimate the potential efficacy and safety of two repurposed drugs, acetylsalicylic acid and ibuprofen, for use as adjunct therapy added to, and compared with, the standard WHO recommended TB regimen

L. ARIAS, K. OTWOMBE, Z. WAJA, N. TUKVADZE, T. KORINTELI, T. MOLOANTOA, K. FONSECA, N. PILLAY, T. SEIPHETLO, D. OUCHI-VERNET, A. SILES, L. CARABIAS, C. QUIÑONES, S. VASHAKIDZE, N. MARTINSON and C. VILAPLANA
Trials. 2023 Jun 28; . doi:10.1186/s13063-023-07448-0; PMID:37370174

Board of Trustees

Collaborators

Accreditations